malondialdehyde has been researched along with Axonal Injury, Diffuse in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmadinejad, M; Karamouzian, S; Khaksari, M; Khazaeli, P; Maiel, M; Mofid, B; Nakhaee, N; Shahrokhi, N; Soltani, Z | 1 |
1 trial(s) available for malondialdehyde and Axonal Injury, Diffuse
| Article | Year |
|---|---|
What are the progesterone-induced changes of the outcome and the serum markers of injury, oxidant activity and inflammation in diffuse axonal injury patients?
Topics: Adult; Antioxidants; Biomarkers; Cytokines; Diffuse Axonal Injury; Humans; Inflammation; Male; Malondialdehyde; Neuroprotective Agents; Progesterone; S100 Calcium Binding Protein beta Subunit; Single-Blind Method | 2016 |